top of page
Leading the Way in Intratumoral Radiotherapeutics
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Meet Alpha Tau at ASTRO Chicago 2021
We are thrilled to announce that the Alpha Tau team will be attending (IN PERSON this year - Finally ! ) the ASTRO conference in Chicago....
Oct 12, 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
JERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to...
Oct 12, 2021
Meet Alpha Tau at ESTRO 2021 - Cancelled
IMPORTANT UPDATE 22/08/2021 : Unfortunately, due to new measures/circumstances related to the coronavirus (COVID-19), Alpha Tau won’t be...
Jul 27, 2021
Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid...
Jul 11, 2021
First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer Trial
Jerusalem, Israel, July 6, 2021 - Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRTTM,...
Jul 8, 2021
bottom of page